175 related articles for article (PubMed ID: 30513742)
1. Classical QSAR and Docking Simulation of 4-Pyridone Derivatives for Their Antimalarial Activity.
Flores-Sumoza M; Alcázar JJ; Márquez E; Mora JR; Lezama J; Puello E
Molecules; 2018 Dec; 23(12):. PubMed ID: 30513742
[TBL] [Abstract][Full Text] [Related]
2. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
3. 2D, 3D-QSAR and molecular docking of 4(1H)-quinolones analogues with antimalarial activities.
Jiménez Villalobos TP; Gaitán Ibarra R; Montalvo Acosta JJ
J Mol Graph Model; 2013 Nov; 46():105-24. PubMed ID: 24185373
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore-similarity-based QSAR (PS-QSAR) for group-specific biological activity predictions.
Prasanth Kumar S; Jasrai YT; Pandya HA; Rawal RM
J Biomol Struct Dyn; 2015; 33(1):56-69. PubMed ID: 24266725
[TBL] [Abstract][Full Text] [Related]
5. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
Kumari M; Chandra S; Tiwari N; Subbarao N
BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
[TBL] [Abstract][Full Text] [Related]
6. A SAR and QSAR study of new artemisinin compounds with antimalarial activity.
Santos CB; Vieira JB; Lobato CC; Hage-Melim LI; Souto RN; Lima CS; Costa EV; Brasil DS; Macêdo WJ; Carvalho JC
Molecules; 2013 Dec; 19(1):367-99. PubMed ID: 24381053
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking and QSAR analyses for understanding the antimalarial activity of some 7-substituted-4-aminoquinoline derivatives.
Shibi IG; Aswathy L; Jisha RS; Masand VH; Divyachandran A; Gajbhiye JM
Eur J Pharm Sci; 2015 Sep; 77():9-23. PubMed ID: 26006759
[TBL] [Abstract][Full Text] [Related]
8. Drug discovery studies on quinoline-based derivatives as potential antimalarial agents.
Sharma R; Patil S; Maurya P
SAR QSAR Environ Res; 2014; 25(3):189-203. PubMed ID: 24601770
[TBL] [Abstract][Full Text] [Related]
9. Novel series of 1,2,4-trioxane derivatives as antimalarial agents.
Rudrapal M; Chetia D; Singh V
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1159-1173. PubMed ID: 28870093
[TBL] [Abstract][Full Text] [Related]
10. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.
Choubey SK; Jeyaraman J
J Mol Graph Model; 2016 Nov; 70():54-69. PubMed ID: 27668885
[TBL] [Abstract][Full Text] [Related]
11. QSAR, docking, dynamic simulation and quantum mechanics studies to explore the recognition properties of cholinesterase binding sites.
Correa-Basurto J; Bello M; Rosales-Hernández MC; Hernández-Rodríguez M; Nicolás-Vázquez I; Rojo-Domínguez A; Trujillo-Ferrara JG; Miranda R; Flores-Sandoval CA
Chem Biol Interact; 2014 Feb; 209():1-13. PubMed ID: 24321698
[TBL] [Abstract][Full Text] [Related]
12. Computational strategies to explore antimalarial thiazine alkaloid lead compounds based on an Australian marine sponge Plakortis Lita.
Aswathy L; Jisha RS; Masand VH; Gajbhiye JM; Shibi IG
J Biomol Struct Dyn; 2017 Aug; 35(11):2407-2429. PubMed ID: 27494993
[TBL] [Abstract][Full Text] [Related]
13. QSAR study on the antimalarial activity of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors.
Hou X; Chen X; Zhang M; Yan A
SAR QSAR Environ Res; 2016; 27(2):101-24. PubMed ID: 26911561
[TBL] [Abstract][Full Text] [Related]
14. Prediction of new Hsp90 inhibitors based on 3,4-isoxazolediamide scaffold using QSAR study, molecular docking and molecular dynamic simulation.
Abbasi M; Sadeghi-Aliabadi H; Amanlou M
Daru; 2017 Jun; 25(1):17. PubMed ID: 28666484
[TBL] [Abstract][Full Text] [Related]
15. Antimalarial activity: a QSAR modeling using CODESSA PRO software.
Katritzky AR; Kulshyn OV; Stoyanova-Slavova I; Dobchev DA; Kuanar M; Fara DC; Karelson M
Bioorg Med Chem; 2006 Apr; 14(7):2333-57. PubMed ID: 16426851
[TBL] [Abstract][Full Text] [Related]
16. Chemometric modeling, docking and in silico design of triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors as antimalarials.
Ojha PK; Roy K
Eur J Med Chem; 2010 Oct; 45(10):4645-56. PubMed ID: 20708304
[TBL] [Abstract][Full Text] [Related]
17. Exploration of 4(1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochrome bc1.
Bueno JM; Herreros E; Angulo-Barturen I; Ferrer S; Fiandor JM; Gamo FJ; Gargallo-Viola D; Derimanov G
Future Med Chem; 2012 Dec; 4(18):2311-23. PubMed ID: 23234553
[TBL] [Abstract][Full Text] [Related]
18. Comparative molecular field analysis and molecular docking studies on novel aryl chalcone derivatives against an important drug target cysteine protease in Plasmodium falciparum.
Thillainayagam M; Anbarasu A; Ramaiah S
J Theor Biol; 2016 Aug; 403():110-128. PubMed ID: 27185536
[TBL] [Abstract][Full Text] [Related]
19. Potent antimalarial 4-pyridones with improved physico-chemical properties.
Bueno JM; Manzano P; García MC; Chicharro J; Puente M; Lorenzo M; García A; Ferrer S; Gómez RM; Fraile MT; Lavandera JL; Fiandor JM; Vidal J; Herreros E; Gargallo-Viola D
Bioorg Med Chem Lett; 2011 Sep; 21(18):5214-8. PubMed ID: 21824778
[TBL] [Abstract][Full Text] [Related]
20. In silico design, chemical synthesis and biological screening of novel 4-(1H)-pyridone-based antimalarial agents.
Audu O; Stander A; Ajani O; Egieyeh S; October N
Chem Biol Drug Des; 2022 May; 99(5):674-687. PubMed ID: 34850571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
